Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease
Saved in:
| Published in: | Stem Cells Translational Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2021
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552829624385536 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Stem Cells Translational Medicine |
| description | |
| discipline_display | Microbiology |
| discipline_facet | Microbiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:62194 |
| institution | FRELIP |
| journal_source_facet | Stem Cells Translational Medicine |
| last_indexed | 2026-06-20T21:27:21.959Z |
| publishDate | 2021 |
| publishDateSort | 2021 |
| record_format | rss_article |
| spellingShingle | Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease Microbiology General Microbiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Microbiology General Microbiology |
| subject_facet | Microbiology General Microbiology |
| title | Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease |
| title_alt | Estudio de vigilancia poscomercialización de fase IV muestra eficacia y seguridad continuas de Stempeucel en pacientes con isquemia crítica de miembros debido a la enfermedad de Buerger Une étude de surveillance post-commercialisation de phase IV montre l'efficacité et la sécurité continues de Stempeucel chez les patients atteints d'ischémie critique des membres due à la maladie de Buerger Estudo de vigilância pós-comercialização fase IV mostra eficácia e segurança contínuas do Stempeucel em pacientes com isquemia crítica de membro devido à doença de Buerger |
| title_auth | Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease |
| title_es_txt | Estudio de vigilancia poscomercialización de fase IV muestra eficacia y seguridad continuas de Stempeucel en pacientes con isquemia crítica de miembros debido a la enfermedad de Buerger |
| title_fr_txt | Une étude de surveillance post-commercialisation de phase IV montre l'efficacité et la sécurité continues de Stempeucel chez les patients atteints d'ischémie critique des membres due à la maladie de Buerger |
| title_full | Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease |
| title_fullStr | Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease |
| title_full_unstemmed | Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease |
| title_pt_txt | Estudo de vigilância pós-comercialização fase IV mostra eficácia e segurança contínuas do Stempeucel em pacientes com isquemia crítica de membro devido à doença de Buerger |
| title_short | Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease |
| title_sort | phase iv postmarketing surveillance study shows continued efficacy and safety of stempeucel in patients with critical limb ischemia due to buerger's disease |
| topic | Microbiology General Microbiology |
| url | https://onlinelibrary.wiley.com/doi/10.1002/sctm.21-0197?af=R |